tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GB:0QAJ Stock Latest News

Dbv Technologies’ Peanut Allergy Study: A Potential Game-Changer for Pediatric Treatment
Company AnnouncementsDbv Technologies’ Peanut Allergy Study: A Potential Game-Changer for Pediatric Treatment
17d ago
0QAJ
Positive Outlook for DBV Technologies SA Driven by Promising Phase 3 Trial and Market Expansion Potential for Viaskin Peanut
PremiumRatings
Positive Outlook for DBV Technologies SA Driven by Promising Phase 3 Trial and Market Expansion Potential for Viaskin Peanut
20d ago
DBVT
DBV Technologies’ Peanut Allergy Patch Study: A Promising Step Forward
PremiumCompany Announcements
DBV Technologies’ Peanut Allergy Patch Study: A Promising Step Forward
23d ago
0QAJ
DBV Technologies announces first subject screened in COMFORT Toddlers trial
PremiumThe Fly
DBV Technologies announces first subject screened in COMFORT Toddlers trial
25d ago
DBVT
Nvidia upgraded, Salesforce downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Nvidia upgraded, Salesforce downgraded: Wall Street’s top analyst calls
2M ago
K
S
Cautious Outlook on DBV Technologies: Sell Rating Amid Commercialization and Market Risks
PremiumRatingsCautious Outlook on DBV Technologies: Sell Rating Amid Commercialization and Market Risks
2M ago
DBVT
DBV Technologies reinstated with a Sell at Goldman Sachs
Premium
The Fly
DBV Technologies reinstated with a Sell at Goldman Sachs
2M ago
DBVT
DBV Technologies price target raised to $21 from $15 at Citizens JMP
Premium
The Fly
DBV Technologies price target raised to $21 from $15 at Citizens JMP
2M ago
DBVT
Buy Rating for DBV Technologies Driven by Promising Viaskin Peanut Potential and Strong Market Opportunity
PremiumRatings
Buy Rating for DBV Technologies Driven by Promising Viaskin Peanut Potential and Strong Market Opportunity
2M ago
DBVT
DBV Technologies files to sell 289.01M ordinary shares for holders
PremiumThe Fly
DBV Technologies files to sell 289.01M ordinary shares for holders
2M ago
DBVT
DBV Technologies price target raised to $16 from $7 at H.C. Wainwright
PremiumThe Fly
DBV Technologies price target raised to $16 from $7 at H.C. Wainwright
3M ago
DBVT
DBV Technologies price target raised to $15 from $10 at Citizens JMP
PremiumThe Fly
DBV Technologies price target raised to $15 from $10 at Citizens JMP
3M ago
DBVT
0QAJ Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings0QAJ Upcoming Earnings Report: What to Expect?
3M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
CDT
NVO
DBV sinks after disclosing ‘substantial doubt’ of going concern
Premium
The Fly
DBV sinks after disclosing ‘substantial doubt’ of going concern
4M ago
DBVT
Promising Outlook for DBV Technologies SA: Accelerated BLA Submission and Revenue Growth Potential
PremiumRatings
Promising Outlook for DBV Technologies SA: Accelerated BLA Submission and Revenue Growth Potential
4M ago
DBVT
DBV reports VITESSE trial sufficient to support BLA, discontinues COMFORT trial
PremiumThe Fly
DBV reports VITESSE trial sufficient to support BLA, discontinues COMFORT trial
4M ago
DBVT
0QAJ Earnings this Week: How Will it Perform?
PremiumPre-Earnings
0QAJ Earnings this Week: How Will it Perform?
5M ago
Viaskin Peanut: A Promising Non-Invasive Solution for Children’s Peanut Allergies with Strong Market Potential
PremiumRatings
Viaskin Peanut: A Promising Non-Invasive Solution for Children’s Peanut Allergies with Strong Market Potential
5M ago
DBVT
DBV Technologies announces three-year results from EPITOPE trial
PremiumThe FlyDBV Technologies announces three-year results from EPITOPE trial
6M ago
DBVT
DBV Technologies announces FDA alignment on Viaskin Peanut patch program pathway
Premium
The Fly
DBV Technologies announces FDA alignment on Viaskin Peanut patch program pathway
7M ago
DBVT
DBV jumps 52% to $4.99 after aligning with FDA on approval pathway
Premium
The Fly
DBV jumps 52% to $4.99 after aligning with FDA on approval pathway
7M ago
DBVT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >